Characterization of Arrhythmia-induced Cardiomyopathy
Recruiting now
Conditions studied: Cardiomyopathy, Arrhythmia-induced Cardiomyopathy (AiCM)
In brief
The goal of the this observational study is to gather clinically available data on patients presenting with a suspicion for arrhythmia-induced cardiomyopathy (AiCM) at the University Hospital Basel.
Key facts
- Study ID
- NCT05662293
- Run by
- University Hospital, Basel, Switzerland
- People needed
- 2700
- Starts
- 2021-06-10
- Expected to finish
- 2027-01-01
- Last updated by the study team
- 2025-03-04
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnostic or suspicion of AiCM as presence of specified keyword in patient's file or as screened by colleagues of the internal medicine or cardiology clinics
- Signed study consent
You may not qualify if…
- Patient's active refusal of the general consent of the University Hospital Basel
- Age <18 years old
- Temporary exclusion criteria: Acute health condition such as myocardial infarction, patients presenting with a major trauma, a sepsis, patients shortly after cardiac surgery, and patients in shock (>100 bpm, <90 systolic BP, evidence of organ dysfunction).
- Life expectancy <1 year (palliative, terminal cancer)
- Retrospective part
- Inclusion Criteria:
- Patients with a reduced left-ventricular ejection fraction (LVEF ≤50%) or a reduction of 15% in the ejection fraction (EF) between two echocardiographies and a concomitant diagnosis of any arrhythmia likely to lead to AiCM within one year before or after diagnosis of the reduced LVEF from 2010-2021
- Exclusion Criteria:
- Age < 18 years old
- Patient's active refusal of the general consent of the University Hospital Basel
- Acute event clearly leading to an acutely reduced LVEF (massive type I myocardial infarction, cardiogenic shock from a coronary or myocardial etiology, septic shock leading to toxic myopathy, hypovolemic shock with reduced EF, cardiac arrest and/or need for resuscitation).
- Patients with life expectancy <1 year (palliative, terminal cancer)
Where it is running
- University Hospital Basel, Department of Cardiology — Basel, Switzerland (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.